athagoras Acquires DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH

ATHAGORAS Group Acquires CSO Pharma Consulting GmbH

November 18, 2024

Healthcare Services

ATHAGORAS Group has acquired CSO Pharma Consulting GmbH to expand and internationalize its pharmacovigilance, medical affairs, quality management and GDP consulting capabilities across the pharma and healthcare sectors. The deal adds a specialized provider of PV and regulatory support to ATHAGORAS' life‑sciences services platform while CSO retains focus on organic growth and continuity for clients and employees.

ATHAGORAS Group Acquires S-cubed Ltd

January 30, 2025

Healthcare Services

ATHAGORAS Holding GmbH (athagoras group) has acquired UK-based regulatory affairs and quality assurance consultancy S-cubed Ltd and integrated it into the athagoras platform. The deal expands athagoras’s life-sciences service capabilities in regulatory affairs, quality assurance and biometrics to support broader European and global client coverage.

Athagoras Acquires Quantify Research

January 8, 2025

Healthcare Services

Athagoras, a Munich-based life sciences consulting platform, has acquired Quantify Research, a Nordic-headquartered specialist in real-world evidence (RWE), health economics (HEOR) and market access. The acquisition expands Athagoras' RWE and market access capabilities and strengthens its presence in the Nordic region and Asia-Pacific to better serve global pharmaceutical clients.

ProPharma Group Acquires Diamond Pharma Services

March 2, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services, a UK-based regulatory affairs, pharmacovigilance, and compliance consultancy. The deal expands ProPharma's global regulatory and pharmacovigilance capabilities and adds Diamond's ~85+ experts and UK footprint to ProPharma's existing suite of services.

Symeres Acquires DGr Pharma

September 15, 2025

Healthcare Services

Symeres has acquired DGr Pharma to strengthen its early‑stage drug development and regulatory consultancy capabilities, accelerating IND‑enabling services for biopharma clients. The deal is supported by Keensight Capital, which backs Symeres and aims to expand the platform's integrated CRDMO offering across discovery and early clinical development.

Bregal Unternehmerkapital Acquires Majority Stake in medavis GmbH

September 26, 2022

Software

Bregal Unternehmerkapital has taken a majority stake in medavis GmbH, a Karlsruhe-based provider of radiology information systems (RIS) with roughly 20% market share in the DACH region. The two founders, Jörg Dittrich and Elmar Kußmaul, retained significant stakes; Bregal plans to support geographic expansion, product development and extension into adjacent healthcare IT areas.